
The next generation of GLP-1 drugs: and how they’ll reshape food and beverage again
The GLP-1 phenomenon is only just getting started: what are the next drugs set to hit the market - and are F&B manufacturers ready for the shift?

The GLP-1 phenomenon is only just getting started: what are the next drugs set to hit the market - and are F&B manufacturers ready for the shift?

With national brands leaning on promotions, retailers are betting on premium private label, better-for-you innovation and ESG commitments to build long-term trust and loyalty

The key will be how the spirits giants tackle the US market

Future Food-Tech San Francisco
What separates startups that move forward from the ones that stall?